[Synthetic cortisol antagonists in the treatment of adrenal gland hypercortisolism. Results of 8 years of use].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000328:Adult; D000616:Aminoglutethimide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D003480:Cushing Syndrome / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone / Q000037:antagonists & inhibitors*; D008297:Male; D008875:Middle Aged; D008939:Mitotane / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000616:Aminoglutethimide; D008939:Mitotane; D002784:Cholesterol; D006854:Hydrocortisone
Les anticortisoliques de synthèse dans la thérapeutique des hypercortisolismes surrénaliens (Bilan de huit ans d'utilisation)